- Home
- KNSA vs ONDS Comparison
KNSA vs ONDS Comparison
Compare KNSA & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | ONDS |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.8B |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | KNSA | ONDS |
|---|---|---|
| Price | $77.47 | $9.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $60.86 | $19.83 |
| AVG Volume (30 Days) | 686.4K | ★ 103.1M |
| Earning Date | 04-28-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 225.00 | N/A |
| EPS | 0.27 | ★ 0.56 |
| Revenue | ★ $677,564,000.00 | $50,731,000.00 |
| Revenue This Year | $37.48 | $662.14 |
| Revenue Next Year | $17.87 | $76.37 |
| P/E Ratio | $285.48 | ★ $16.62 |
| Revenue Growth | 60.09 | ★ 605.31 |
| 52 Week Low | $32.69 | $3.20 |
| 52 Week High | $82.94 | $15.28 |
Technical Indicators
Market Signals| Indicator | KNSA | ONDS |
|---|---|---|
| Relative Strength Index (RSI) | 65.81 | 62.79 |
| Support Level | $40.06 | $8.79 |
| Resistance Level | $82.94 | $10.12 |
| Average True Range (ATR) | 3.75 | 0.65 |
| MACD | 0.20 | 0.26 |
| Stochastic Oscillator | 76.67 | 94.17 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About ONDS Ondas Holdings Inc.
Ondas Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system. Geographically, the company operates in Israel, Germany, United Arab Emirates, United States, and Other Countries. It derives maximum revenue from Israel.